MaxCyte, Inc. · NASDAQ:MXCT
Masoud Maher bought 100,000 MaxCyte, Inc. shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 18, 2026
On Nov 17, 2026, Masoud Maher (Director, President and CEO) bought 100,000 MaxCyte, Inc. shares at US$1.21 for US$121K, leaving 575,000 shares. Filed Nov 18, 2026 (Form 4).
- Bought
- 100,000 shares
- Price
- US$1.21
- Value
- US$121K
- Holding after
- 575,000 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock | Buy | 100,000 | US$1.21 | 575,000 | Direct |
Source
Download original · View original at SEC
Related
- MaxCyte, Inc.
- Masoud Maher
- MaxCyte, Inc. shareholders
- Schedule 13D · Liontrust Investment Partners LLP · Nov 2, 2026
- Schedule 13D · Liontrust Investment Partners LLP · Oct 15, 2026
- Schedule 13D · River Global Investors LLP · Aug 4, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Johnston John Joseph · Jun 22, 2026